1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Asia Pacific Biologics Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Preference for Outsourcing Manufacturing Operations

4.2 Market Restraints

4.2.1 High Cost of Biologics

4.3 Market Opportunities

4.3.1 Evolution of Biotechnology in Developing Regions

4.3.2 Gene and Cell Therapy Advancements in Biologics

4.4 Future Trends

4.4.1 Strategic Initiatives by Companies

4.5 Impact of Drivers and Restraints:

5. Biologics Market - Asia Pacific Analysis

5.1 Asia Pacific Biologics Market Revenue (US$ Million), 2021-2031

5.2 Asia Pacific Biologics Market Forecast Analysis

6. Asia Pacific Biologics Market Analysis - by Product

6.1 Monoclonal Antibodies

6.1.1 Overview

6.1.2 Monoclonal Antibodies: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Vaccine

6.2.1 Overview

6.2.2 Vaccine: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.3 Recombinant Hormones/Proteins

6.3.1 Overview

6.3.2 Recombinant Hormones/Proteins: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.4 Cell and Gene Therapy

6.4.1 Overview

6.4.2 Cell and Gene Therapy: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Biologics Market Analysis - by Application

7.1 Cancer

7.1.1 Overview

7.1.2 Cancer: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Infectious Diseases

7.2.1 Overview

7.2.2 Infectious Diseases: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Autoimmune Diseases

7.3.1 Overview

7.3.2 Autoimmune Diseases: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Biologics Market Analysis - by Source

8.1 Mammalian

8.1.1 Overview

8.1.2 Mammalian: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Microbial

8.2.1 Overview

8.2.2 Microbial: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Biologics Market Analysis - by Manufacturing

9.1 Outsourced

9.1.1 Overview

9.1.2 Outsourced: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 In-house

9.2.1 Overview

9.2.2 In-house: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Biologics Market - Country Analysis

10.1 Asia Pacific

10.1.1 Asia Pacific Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Asia Pacific Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 China: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.2.1 China: Asia Pacific Biologics Market Share - by Product

10.1.1.2.2 China: Asia Pacific Biologics Market Share - by Application

10.1.1.2.3 China: Asia Pacific Biologics Market Share - by Source

10.1.1.2.4 China: Asia Pacific Biologics Market Share - by Manufacturing

10.1.1.3 India: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.3.1 India: Asia Pacific Biologics Market Share - by Product

10.1.1.3.2 India: Asia Pacific Biologics Market Share - by Application

10.1.1.3.3 India: Asia Pacific Biologics Market Share - by Source

10.1.1.3.4 India: Asia Pacific Biologics Market Share - by Manufacturing

10.1.1.4 Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.4.1 Japan: Asia Pacific Biologics Market Share - by Product

10.1.1.4.2 Japan: Asia Pacific Biologics Market Share - by Application

10.1.1.4.3 Japan: Asia Pacific Biologics Market Share - by Source

10.1.1.4.4 Japan: Asia Pacific Biologics Market Share - by Manufacturing

10.1.1.5 South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.5.1 South Korea: Asia Pacific Biologics Market Share - by Product

10.1.1.5.2 South Korea: Asia Pacific Biologics Market Share - by Application

10.1.1.5.3 South Korea: Asia Pacific Biologics Market Share - by Source

10.1.1.5.4 South Korea: Asia Pacific Biologics Market Share - by Manufacturing

10.1.1.6 Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.6.1 Australia: Asia Pacific Biologics Market Share - by Product

10.1.1.6.2 Australia: Asia Pacific Biologics Market Share - by Application

10.1.1.6.3 Australia: Asia Pacific Biologics Market Share - by Source

10.1.1.6.4 Australia: Asia Pacific Biologics Market Share - by Manufacturing

10.1.1.7 Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Biologics Market Share - by Product

10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Biologics Market Share - by Application

10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Biologics Market Share - by Source

10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Biologics Market Share - by Manufacturing

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 AbbVie Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Pfizer Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Samsung Biologics Co Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ADMA Biologics, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 WuXi Biologics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Catalent Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AGC Biologics AS

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 AstraZeneca Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Amgen Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Nitto Avecia

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Quality Assistance s.a.

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Asia Pacific Biologics Market Segmentation

Table 2. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product

Table 4. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source

Table 6. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Manufacturing

Table 7. Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 8. China: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 9. China: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 10. China: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 11. China: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 12. India: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 13. India: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 14. India: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 15. India: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 16. Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 17. Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 18. Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 19. Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 20. South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 21. South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 22. South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 23. South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 24. Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 25. Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 26. Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 27. Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 28. Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 29. Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 30. Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 31. Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

List of Figures

Figure 1. Asia Pacific Biologics Market Segmentation - Country

Figure 2. Asia Pacific Biologics Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Biologics Market Revenue (US$ Million), 2021-2031

Figure 5. Asia Pacific Biologics Market Share (%) - by Product (2023 and 2031)

Figure 6. Monoclonal Antibodies: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Vaccine: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Recombinant Hormones/Proteins: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Cell and Gene Therapy: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Others: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Asia Pacific Biologics Market Share (%) - by Application (2023 and 2031)

Figure 12. Cancer: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 13. Infectious Diseases: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Autoimmune Diseases: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Others: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Asia Pacific Biologics Market Share (%) - by Source (2023 and 2031)

Figure 17. Mammalian: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Microbial: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. Asia Pacific Biologics Market Share (%) - by Manufacturing (2023 and 2031)

Figure 20. Outsourced: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. In-house: Asia Pacific Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. Asia Pacific Biologics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. China: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. India: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 25. Japan: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 26. South Korea: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 27. Australia: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 28. Rest of Asia Pacific: Asia Pacific Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)